APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Medicine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ophthalmic Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17401914032 January 2026184 pages

Choose your research edition.

Industry ResearchOphthalmic Medicine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Medicine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Ophthalmic Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Medicine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Medicine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Ophthalmic Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ophthalmic Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmic Medicine include Zhejiang Shapuaisi Pharmaceutical, Shenyang Xingqi Pharmaceutical Co.,Ltd., Chengdu Kanghong Pharmaceutical Group, Santen Pharmaceutica, Novaliq, Mentholatum, Bausch Health and Alcon NV, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ophthalmic Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmic Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmic Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ophthalmic Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Ophthalmic Medicine Segment by Company

Zhejiang Shapuaisi Pharmaceutical

Shenyang Xingqi Pharmaceutical Co.,Ltd.

Chengdu Kanghong Pharmaceutical Group

Santen Pharmaceutica

Novaliq

Mentholatum

Bausch Health

Alcon NV

Ophthalmic Medicine Segment by Type

Eye Drops

Gelling Agent

Tablet

Eye Ointment

Injection

Ophthalmic Medicine Segment by Application

Cataract

Anti-infective

Anti-fatigue and Dryness

Ophthalmic Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ophthalmic Medicine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmic Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ophthalmic Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ophthalmic Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ophthalmic Medicine Industry Trends Table 2. Ophthalmic Medicine Industry Drivers Table 3. Ophthalmic Medicine Industry Opportunities and Challenges Table 4. Ophthalmic Medicine Industry Restraints Table 5. Global Ophthalmic Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ophthalmic Medicine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ophthalmic Medicine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Ophthalmic Medicine Sales Market Share by Manufacturers Table 9. Global Ophthalmic Medicine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Ophthalmic Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ophthalmic Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ophthalmic Medicine Manufacturers, Product Type & Application Table 13. Global Ophthalmic Medicine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ophthalmic Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Eye Drops Table 17. Major Manufacturers of Gelling Agent Table 18. Major Manufacturers of Tablet Table 19. Major Manufacturers of Eye Ointment Table 20. Major Manufacturers of Injection Table 21. Global Ophthalmic Medicine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Ophthalmic Medicine Sales by Type (2021-2026) & (K Units) Table 23. Global Ophthalmic Medicine Sales by Type (2027-2032) & (K Units) Table 24. Global Ophthalmic Medicine Sales Market Share by Type (2021-2026) Table 25. Global Ophthalmic Medicine Sales Market Share by Type (2027-2032) Table 26. Global Ophthalmic Medicine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Ophthalmic Medicine Revenue by Type (2021-2026) & (K Units) Table 28. Global Ophthalmic Medicine Revenue by Type (2027-2032) & (K Units) Table 29. Global Ophthalmic Medicine Revenue Market Share by Type (2021-2026) Table 30. Global Ophthalmic Medicine Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Cataract Table 32. Major Manufacturers of Anti-infective Table 33. Major Manufacturers of Anti-fatigue and Dryness Table 34. Global Ophthalmic Medicine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Ophthalmic Medicine Sales by Application (2021-2026) & (K Units) Table 36. Global Ophthalmic Medicine Sales by Application (2027-2032) & (K Units) Table 37. Global Ophthalmic Medicine Sales Market Share by Application (2021-2026) Table 38. Global Ophthalmic Medicine Sales Market Share by Application (2027-2032) Table 39. Global Ophthalmic Medicine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Ophthalmic Medicine Revenue by Application (2021-2026) & (K Units) Table 41. Global Ophthalmic Medicine Revenue by Application (2027-2032) & (K Units) Table 42. Global Ophthalmic Medicine Revenue Market Share by Application (2021-2026) Table 43. Global Ophthalmic Medicine Revenue Market Share by Application (2027-2032) Table 44. Global Ophthalmic Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Ophthalmic Medicine Sales by Region (2021-2026) & (K Units) Table 46. Global Ophthalmic Medicine Sales Market Share by Region (2021-2026) Table 47. Global Ophthalmic Medicine Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Ophthalmic Medicine Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Ophthalmic Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 51. North America Ophthalmic Medicine Sales by Country (2027-2032) & (K Units) Table 52. Europe Ophthalmic Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 54. Europe Ophthalmic Medicine Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Ophthalmic Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Ophthalmic Medicine Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Ophthalmic Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Ophthalmic Medicine Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Ophthalmic Medicine Sales by Country (2027-2032) & (K Units) Table 61. Global Ophthalmic Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Ophthalmic Medicine Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Ophthalmic Medicine Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Ophthalmic Medicine Revenue Market Share by Region (2021-2026) Table 65. Global Ophthalmic Medicine Revenue Market Share by Region (2027-2032) Table 66. Zhejiang Shapuaisi Pharmaceutical Company Information Table 67. Zhejiang Shapuaisi Pharmaceutical Business Overview Table 68. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolio Table 70. Zhejiang Shapuaisi Pharmaceutical Recent Development Table 71. Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information Table 72. Shenyang Xingqi Pharmaceutical Co.,Ltd. Business Overview Table 73. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolio Table 75. Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Development Table 76. Chengdu Kanghong Pharmaceutical Group Company Information Table 77. Chengdu Kanghong Pharmaceutical Group Business Overview Table 78. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolio Table 80. Chengdu Kanghong Pharmaceutical Group Recent Development Table 81. Santen Pharmaceutica Company Information Table 82. Santen Pharmaceutica Business Overview Table 83. Santen Pharmaceutica Ophthalmic Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Santen Pharmaceutica Ophthalmic Medicine Product Portfolio Table 85. Santen Pharmaceutica Recent Development Table 86. Novaliq Company Information Table 87. Novaliq Business Overview Table 88. Novaliq Ophthalmic Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Novaliq Ophthalmic Medicine Product Portfolio Table 90. Novaliq Recent Development Table 91. Mentholatum Company Information Table 92. Mentholatum Business Overview Table 93. Mentholatum Ophthalmic Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Mentholatum Ophthalmic Medicine Product Portfolio Table 95. Mentholatum Recent Development Table 96. Bausch Health Company Information Table 97. Bausch Health Business Overview Table 98. Bausch Health Ophthalmic Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Bausch Health Ophthalmic Medicine Product Portfolio Table 100. Bausch Health Recent Development Table 101. Alcon NV Company Information Table 102. Alcon NV Business Overview Table 103. Alcon NV Ophthalmic Medicine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Alcon NV Ophthalmic Medicine Product Portfolio Table 105. Alcon NV Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Ophthalmic Medicine Distributors List Table 109. Ophthalmic Medicine Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Ophthalmic Medicine Product Image Figure 2. Global Ophthalmic Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Medicine Sales (2021-2032) & (K Units) Figure 5. Global Ophthalmic Medicine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ophthalmic Medicine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Eye Drops Image Figure 9. Gelling Agent Image Figure 10. Tablet Image Figure 11. Eye Ointment Image Figure 12. Injection Image Figure 13. Global Ophthalmic Medicine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Ophthalmic Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Ophthalmic Medicine Sales Market Share by Type (2021-2032) Figure 16. Global Ophthalmic Medicine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Ophthalmic Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Ophthalmic Medicine Revenue Market Share by Type (2021-2032) Figure 19. Cataract Image Figure 20. Anti-infective Image Figure 21. Anti-fatigue and Dryness Image Figure 22. Global Ophthalmic Medicine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Ophthalmic Medicine Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Ophthalmic Medicine Sales Market Share by Application (2021-2032) Figure 25. Global Ophthalmic Medicine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Ophthalmic Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Ophthalmic Medicine Revenue Market Share by Application (2021-2032) Figure 28. North America Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Ophthalmic Medicine Sales Market Share by Country (2021-2032) Figure 30. U.S. Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Ophthalmic Medicine Sales Market Share by Country (2021-2032) Figure 35. Germany Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Ophthalmic Medicine Sales Market Share by Country (2021-2032) Figure 42. China Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Ophthalmic Medicine Sales Market Share by Country (2021-2032) Figure 50. Brazil Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Ophthalmic Medicine Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Ophthalmic Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Ophthalmic Medicine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Ophthalmic Medicine Revenue (2021-2032) & (US$ Million) Figure 61. North America Ophthalmic Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Ophthalmic Medicine Revenue (2021-2032) & (US$ Million) Figure 63. Europe Ophthalmic Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Ophthalmic Medicine Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Ophthalmic Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Ophthalmic Medicine Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Ophthalmic Medicine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Ophthalmic Medicine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Ophthalmic Medicine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Eye Drops
  • Gelling Agent
  • Tablet
  • Eye Ointment
  • Injection
Applications
  • Cataract
  • Anti-infective
  • Anti-fatigue and Dryness
Companies covered
  • Zhejiang Shapuaisi Pharmaceutical
  • Shenyang Xingqi Pharmaceutical Co.,Ltd.
  • Chengdu Kanghong Pharmaceutical Group
  • Santen Pharmaceutica
  • Novaliq
  • Mentholatum
  • Bausch Health
  • Alcon NV

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ophthalmic Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ophthalmic Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ophthalmic Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ophthalmic Medicine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ophthalmic Medicine Market Dynamics
  1. 2.1 Ophthalmic Medicine Industry Trends
  2. 2.2 Ophthalmic Medicine Industry Drivers
  3. 2.3 Ophthalmic Medicine Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Medicine Industry Restraints
3 Ophthalmic Medicine Market by Manufacturers
  1. 3.1 Global Ophthalmic Medicine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ophthalmic Medicine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ophthalmic Medicine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ophthalmic Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmic Medicine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ophthalmic Medicine Manufacturers, Product Type & Application
  7. 3.7 Global Ophthalmic Medicine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmic Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmic Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmic Medicine Tier 1, Tier 2, and Tier 3
4 Ophthalmic Medicine Market by Type
  1. 4.1 Ophthalmic Medicine Type Introduction
  2. 4.1.1 Eye Drops
  3. 4.1.2 Gelling Agent
  4. 4.1.3 Tablet
  5. 4.1.4 Eye Ointment
  6. 4.1.5 Injection
  7. 4.2 Global Ophthalmic Medicine Sales by Type
  8. 4.2.1 Global Ophthalmic Medicine Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Ophthalmic Medicine Sales by Type (2021-2032)
  10. 4.2.3 Global Ophthalmic Medicine Sales Market Share by Type (2021-2032)
  11. 4.3 Global Ophthalmic Medicine Revenue by Type
  12. 4.3.1 Global Ophthalmic Medicine Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Ophthalmic Medicine Revenue by Type (2021-2032)
  14. 4.3.3 Global Ophthalmic Medicine Revenue Market Share by Type (2021-2032)
5 Ophthalmic Medicine Market by Application
  1. 5.1 Ophthalmic Medicine Application Introduction
  2. 5.1.1 Cataract
  3. 5.1.2 Anti-infective
  4. 5.1.3 Anti-fatigue and Dryness
  5. 5.2 Global Ophthalmic Medicine Sales by Application
  6. 5.2.1 Global Ophthalmic Medicine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ophthalmic Medicine Sales by Application (2021-2032)
  8. 5.2.3 Global Ophthalmic Medicine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Ophthalmic Medicine Revenue by Application
  10. 5.3.1 Global Ophthalmic Medicine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ophthalmic Medicine Revenue by Application (2021-2032)
  12. 5.3.3 Global Ophthalmic Medicine Revenue Market Share by Application (2021-2032)
6 Global Ophthalmic Medicine Sales by Region
  1. 6.1 Global Ophthalmic Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmic Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Ophthalmic Medicine Sales by Region (2021-2026)
  4. 6.2.2 Global Ophthalmic Medicine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ophthalmic Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ophthalmic Medicine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ophthalmic Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ophthalmic Medicine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ophthalmic Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ophthalmic Medicine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ophthalmic Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ophthalmic Medicine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ophthalmic Medicine Revenue by Region
  1. 7.1 Global Ophthalmic Medicine Revenue by Region
  2. 7.1.1 Global Ophthalmic Medicine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ophthalmic Medicine Revenue by Region (2021-2026)
  4. 7.1.3 Global Ophthalmic Medicine Revenue by Region (2027-2032)
  5. 7.1.4 Global Ophthalmic Medicine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ophthalmic Medicine Revenue (2021-2032)
  8. 7.2.2 North America Ophthalmic Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ophthalmic Medicine Revenue (2021-2032)
  11. 7.3.2 Europe Ophthalmic Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ophthalmic Medicine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ophthalmic Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ophthalmic Medicine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ophthalmic Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Shapuaisi Pharmaceutical
  2. 8.1.1 Zhejiang Shapuaisi Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Shapuaisi Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Shapuaisi Pharmaceutical Ophthalmic Medicine Product Portfolio
  6. 8.1.5 Zhejiang Shapuaisi Pharmaceutical Recent Developments
  7. 8.2 Shenyang Xingqi Pharmaceutical Co.,Ltd.
  8. 8.2.1 Shenyang Xingqi Pharmaceutical Co.,Ltd. Company Information
  9. 8.2.2 Shenyang Xingqi Pharmaceutical Co.,Ltd. Business Overview
  10. 8.2.3 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shenyang Xingqi Pharmaceutical Co.,Ltd. Ophthalmic Medicine Product Portfolio
  12. 8.2.5 Shenyang Xingqi Pharmaceutical Co.,Ltd. Recent Developments
  13. 8.3 Chengdu Kanghong Pharmaceutical Group
  14. 8.3.1 Chengdu Kanghong Pharmaceutical Group Company Information
  15. 8.3.2 Chengdu Kanghong Pharmaceutical Group Business Overview
  16. 8.3.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Medicine Product Portfolio
  18. 8.3.5 Chengdu Kanghong Pharmaceutical Group Recent Developments
  19. 8.4 Santen Pharmaceutica
  20. 8.4.1 Santen Pharmaceutica Company Information
  21. 8.4.2 Santen Pharmaceutica Business Overview
  22. 8.4.3 Santen Pharmaceutica Ophthalmic Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Santen Pharmaceutica Ophthalmic Medicine Product Portfolio
  24. 8.4.5 Santen Pharmaceutica Recent Developments
  25. 8.5 Novaliq
  26. 8.5.1 Novaliq Company Information
  27. 8.5.2 Novaliq Business Overview
  28. 8.5.3 Novaliq Ophthalmic Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novaliq Ophthalmic Medicine Product Portfolio
  30. 8.5.5 Novaliq Recent Developments
  31. 8.6 Mentholatum
  32. 8.6.1 Mentholatum Company Information
  33. 8.6.2 Mentholatum Business Overview
  34. 8.6.3 Mentholatum Ophthalmic Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mentholatum Ophthalmic Medicine Product Portfolio
  36. 8.6.5 Mentholatum Recent Developments
  37. 8.7 Bausch Health
  38. 8.7.1 Bausch Health Company Information
  39. 8.7.2 Bausch Health Business Overview
  40. 8.7.3 Bausch Health Ophthalmic Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bausch Health Ophthalmic Medicine Product Portfolio
  42. 8.7.5 Bausch Health Recent Developments
  43. 8.8 Alcon NV
  44. 8.8.1 Alcon NV Company Information
  45. 8.8.2 Alcon NV Business Overview
  46. 8.8.3 Alcon NV Ophthalmic Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Alcon NV Ophthalmic Medicine Product Portfolio
  48. 8.8.5 Alcon NV Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ophthalmic Medicine Value Chain Analysis
  2. 9.1.1 Ophthalmic Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ophthalmic Medicine Production Mode & Process
  6. 9.2 Ophthalmic Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ophthalmic Medicine Distributors
  9. 9.2.3 Ophthalmic Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst